DIABNEXT® won the 2017 CES INNOVATION AWARD in the BIOTECH SECTION with its patented CLIPSULIN device that automatically fills patients’ logbooks with insulin injection data, and is compatible with all insulin pens on the market.
Finalist of the Innovation Award at the Lyfebulb – Novo Nordisk Innovation summit 2017
The Lyfebulb-Novo Nordisk Innovation Summit 2017 will recognize and empower international Patient Entrepreneurs with big ideas that disrupt the future of diabetes management. DIABNEXT® CEO, Laurent Nicolas, was selected as one of the Patient Entrepreneur Finalists. Patient Entrepreneurs have a unique ability to create value-adding disease management solutions beyond therapy.
Link to the Innovation Summit 2017
MEDICAL DEVICE COMPANY OF THE YEAR – PM360 TRAILBLAZER AWARDS 2017
DIABNEXT® won The Trailblazer Company of the Year Award in the Medical Device category in 2017. Since 2009, nominations have been judged by the PM360 Editorial Advisory Board, a distinguished cross-section of industry experts. Winning companies are selected based on their ability to excel in three main aspects: Innovation, Talent Development, and Social Responsibility.
Winner of the French Governement Diabetes Innovation award
DIABNEXT®, a proud member of FRENCH TECH, won the prestigious 2017 DIABETES FRENCH GOVERNMENT DIABETES INNOVATION CHALLENGE organized by the French government and its healthcare arm “Assurance Maladie”. DIABNEXT® is currently working hand in hand with the French Healthcare Ministry to discuss product features and reimbursement methods for our automated diabetes self-management solution.
Juniper Research – Best Consumer Product award 2017
DIABNEXT® won the prestigious Juniper Research award for our patented insulin data-recording device, CLIPSULIN®, in the “Best Consumer Product 2017” category. The expert panel jury based their selection on three major criteria: Product Features, User Benefits, and Innovation.
AAGEF Award at the French Founder – French Morning Start up Tour
Winner of the FRENCH TECH START UP COMPETITION in New York, DIABNEXT® represented Boston, Massachusetts in the Final Competition for the Best French Tech Start-up in New York, in 2017.
After a series of local competitions held across the United States and Canada in June 2017, eight startups have been selected to compete in the finals of the Startup Tour.
The juries that chose these distinguished startups were composed of entrepreneurs, investors, innovators, and change makers located in North America.
Link to the Sartup Tour 2017
Finalist of the 4YFN Americas Award at Mobile World Congress Americas 2017
DIABNEXT® was a finalist at the Mobile World Congress Americas in San Francisco, in the IoT/AI stream for its digital innovation in diabetes management by combining smart devices, cloud, and mobile solutions for better self-management and monitoring.
The Great Innovation Award ID17
The judges of The Great Innovation Award of Le Petit Web awarded the Bronze ID, in the Society category, to DIABNEXT®, the next-generation of diabetes care.
Le Petit Web, an online media source that specializes in delivering the news of interactive marketing and digital innovation, unveiled the 4th edition of the Great Award of Digital Innovation, ID17, the biggest competition for innovation in France.
Link to the ID2017 Awards